Back to Archived Journals » Oncolytic Virotherapy » Volume 6
Oncolytic Virotherapy ceased publishing in January 2023. All articles that have been published in Oncolytic Virotherapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Oncolytic Virotherapy
ISSN: 2253-1572
- View all (70)
- Volume 10, 2021 (1)
- Volume 9, 2020 (2)
- Volume 8, 2019 (6)
- Volume 7, 2018 (11)
- Volume 6, 2017 (6)
- Volume 5, 2016 (10)
- Volume 4, 2015 (20)
- Volume 3, 2014 (8)
- Volume 2, 2013 (5)
- Volume 1, 2012 (1)
Archive: Volume 6, 2017
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
Yokoda R, Nagalo BM, Vernon B, Oklu R, Albadawi H, DeLeon TT, Zhou Y, Egan JB, Duda DG, Borad MJ
Oncolytic Virotherapy 2017, 6:39-49
Published Date: 8 November 2017
Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity
Hotta Y, Kasuya H, Bustos I, Naoe Y, Ichinose T, Tanaka M, Kodera Y
Oncolytic Virotherapy 2017, 6:31-38
Published Date: 13 March 2017
Proinflammatory response induced by Newcastle disease virus in tumor and normal cells
Ginting TE, Suryatenggara J, Christian S, Mathew G
Oncolytic Virotherapy 2017, 6:21-30
Published Date: 3 March 2017
Editorial announcing PubMed indexing of Oncolytic Virotherapy
Farassati F
Oncolytic Virotherapy 2017, 6:19-20
Published Date: 15 February 2017
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
Babiker HM, Riaz IB, Husnain M, Borad MJ
Oncolytic Virotherapy 2017, 6:11-18
Published Date: 9 February 2017
Novel oncolytic viral therapies in patients with thoracic malignancies
Ahmad Z, Kratzke RA
Oncolytic Virotherapy 2017, 6:1-9
Published Date: 21 December 2016